A detailed history of Citigroup Inc transactions in Natera, Inc. stock. As of the latest transaction made, Citigroup Inc holds 95,593 shares of NTRA stock, worth $16.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
95,593
Previous 166,069 42.44%
Holding current value
$16.1 Million
Previous $18 Million 32.44%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$97.75 - $129.67 $6.89 Million - $9.14 Million
-70,476 Reduced 42.44%
95,593 $12.1 Million
Q2 2024

Aug 12, 2024

SELL
$85.28 - $112.6 $642,584 - $848,441
-7,535 Reduced 4.34%
166,069 $18 Million
Q1 2024

May 10, 2024

SELL
$59.21 - $92.9 $2.56 Million - $4.02 Million
-43,241 Reduced 19.94%
173,604 $15.9 Million
Q4 2023

Feb 09, 2024

BUY
$37.55 - $62.64 $1.29 Million - $2.16 Million
34,411 Added 18.86%
216,845 $13.6 Million
Q3 2023

Nov 09, 2023

BUY
$43.4 - $62.52 $2.84 Million - $4.09 Million
65,383 Added 55.86%
182,434 $8.07 Million
Q2 2023

Aug 10, 2023

SELL
$47.08 - $55.16 $1.69 Million - $1.98 Million
-35,858 Reduced 23.45%
117,051 $5.7 Million
Q1 2023

May 11, 2023

BUY
$36.57 - $58.29 $2.03 Million - $3.24 Million
55,603 Added 57.14%
152,909 $8.49 Million
Q4 2022

Feb 09, 2023

SELL
$34.17 - $47.91 $986,897 - $1.38 Million
-28,882 Reduced 22.89%
97,306 $3.91 Million
Q3 2022

Nov 10, 2022

SELL
$36.93 - $56.68 $1.14 Million - $1.74 Million
-30,752 Reduced 19.59%
126,188 $5.53 Million
Q2 2022

Aug 10, 2022

BUY
$28.13 - $44.54 $2.81 Million - $4.44 Million
99,720 Added 174.27%
156,940 $5.56 Million
Q1 2022

May 12, 2022

SELL
$30.32 - $91.33 $291,344 - $877,589
-9,609 Reduced 14.38%
57,220 $2.33 Million
Q4 2021

Feb 10, 2022

SELL
$86.26 - $119.0 $126,025 - $173,859
-1,461 Reduced 2.14%
66,829 $6.24 Million
Q3 2021

Nov 10, 2021

BUY
$100.17 - $126.36 $6.84 Million - $8.63 Million
68,290 New
68,290 $7.61 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.